Clinical Scorecard: Reoperative Urethroplasty for Treating Recurrent Urethral Strictures in Men: A Comprehensive Review

At a Glance

Key Highlights

• Open reconstructive urethroplasty has early success rates of 79–95%, but 14–42% of patients experience recurrence requiring further treatment.
• Redo-urethroplasty shows higher success rates (67–92%) compared to direct vision internal urethrotomy (DVIU), which has high failure rates up to 100% in recurrent strictures.
• There is a lack of standardized guidelines for managing recurrent urethral strictures post-urethroplasty, resulting in wide practice variation.

Guideline-Based Recommendations

Diagnosis

• Use endoscopic assessment to evaluate recurrent strictures, especially prior to DVIU.

Management

• Consider redo-urethroplasty as the preferred treatment for recurrent strictures due to higher success rates.
• Reserve DVIU for short (<1 cm), bulbar recurrent strictures or patients unfit for open surgery.
• Avoid repeated endoscopic treatments to prevent chronic strictures requiring lifelong self-dilatation.

Monitoring & Follow-up

• Follow-up should include assessment of re-stricture rates and maximum urinary flow rate (Qmax).
• Patient-reported quality of life and symptom questionnaires are important for postoperative monitoring.

Risks

• Repeated DVIU is associated with high failure rates and complications such as bleeding and infection.
• Prior endoscopic treatments increase risk of urethroplasty failure due to scarring and poor tissue quality.

Patient & Prescribing Data

Men with recurrent urethral strictures after failed primary urethroplasty

Redo-urethroplasty offers better long-term success compared to repeated endoscopic treatments; DVIU is limited to select patients with short strictures or significant comorbidities.

Clinical Best Practices

• Perform thorough preoperative evaluation including stricture length, location, and prior treatments.
• Select surgical technique based on stricture characteristics and patient factors.
• Use standardized outcome measures such as re-stricture rates and Qmax to evaluate success.
• Incorporate patient-reported outcomes in follow-up to assess quality of life.
• Recognize that recurrent strictures are more complex due to scarring and require experienced reconstructive surgeons.

References

• Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines
• PROSPERO registration CRD42018088874
• Clinical trials registry